Low-risk thyroid cancer may not benefit from radioiodine treatment
Share This
Twitter
Facebook
Outcomes for low-risk thyroid cancer patients treated with thyroidectomy, then radioiodine, were no better than those given thyroidectomy only, according to a French study published in The New England Journal of Medicine.
Our website uses cookies to provide you with a better online experience.
If you continue to use our site without changing your browser settings,
we'll assume you are happy to receive cookies.
Please read our cookie policy for more information.